RIZZI, Anna
 Distribuzione geografica
Continente #
NA - Nord America 52
EU - Europa 47
AS - Asia 6
OC - Oceania 1
Totale 106
Nazione #
US - Stati Uniti d'America 52
IT - Italia 35
CN - Cina 6
DE - Germania 5
FR - Francia 5
AU - Australia 1
ES - Italia 1
SE - Svezia 1
Totale 106
Città #
Ferrara di Monte Baldo 22
Ashburn 14
Ferrara 11
Boardman 8
Chicago 6
Athens 2
Henderson 2
Los Angeles 2
Aachen 1
Baltimore 1
Berlin 1
Buffalo 1
Hangzhou 1
Herndon 1
Indianapolis 1
Jiangchuanlu 1
Lombard 1
New York 1
Padova 1
Perrysburg 1
Presque Isle 1
Providence 1
Santa Clara 1
Santa Cruz de Tenerife 1
Sindelfingen 1
Staten Island 1
Sydney 1
Vicenza 1
Totale 87
Nome #
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors, file e309ade3-ecc7-3969-e053-3a05fe0a2c94 34
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad?, file e309ade5-394a-3969-e053-3a05fe0a2c94 8
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies., file e309ade0-340b-3969-e053-3a05fe0a2c94 7
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24., file e309ade0-2a4a-3969-e053-3a05fe0a2c94 5
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68., file e309ade2-090f-3969-e053-3a05fe0a2c94 5
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor, file e309ade0-3081-3969-e053-3a05fe0a2c94 4
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies, file e309ade0-3784-3969-e053-3a05fe0a2c94 4
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze., file e309ade0-4aaf-3969-e053-3a05fe0a2c94 4
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1, file e309ade0-4314-3969-e053-3a05fe0a2c94 3
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS., file e309ade0-289d-3969-e053-3a05fe0a2c94 2
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist., file e309ade0-3c8b-3969-e053-3a05fe0a2c94 2
Pharmacological characterization of tachykinin tetrabranched derivatives, file e309ade0-3fd1-3969-e053-3a05fe0a2c94 2
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations, file e309ade1-09f6-3969-e053-3a05fe0a2c94 2
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors, file e309ade1-97a2-3969-e053-3a05fe0a2c94 2
In vitro pharmacological profile of peptide III-BTD: A novel ligand for nociceptin/orphanin FQ and opioid receptors, file e1d74285-18a7-4655-af08-9fa21a758e12 1
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ., file e309ade0-2134-3969-e053-3a05fe0a2c94 1
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation, file e309ade0-22e0-3969-e053-3a05fe0a2c94 1
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior, file e309ade0-22e5-3969-e053-3a05fe0a2c94 1
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A, file e309ade0-22f7-3969-e053-3a05fe0a2c94 1
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies, file e309ade0-2303-3969-e053-3a05fe0a2c94 1
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor, file e309ade0-246b-3969-e053-3a05fe0a2c94 1
Synthesis and biological activity of human neuropeptide S analogues modified in position 2, file e309ade0-2575-3969-e053-3a05fe0a2c94 1
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice, file e309ade0-264e-3969-e053-3a05fe0a2c94 1
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists., file e309ade0-2819-3969-e053-3a05fe0a2c94 1
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists., file e309ade0-2a4c-3969-e053-3a05fe0a2c94 1
A new ligand for the urotensin II receptor, file e309ade0-2c4b-3969-e053-3a05fe0a2c94 1
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor, file e309ade0-38c8-3969-e053-3a05fe0a2c94 1
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor, file e309ade0-395d-3969-e053-3a05fe0a2c94 1
null, file e309ade0-3e2a-3969-e053-3a05fe0a2c94 1
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives, file e309ade0-3fd2-3969-e053-3a05fe0a2c94 1
Pharmacology of the Kallikrein-Kinin system, file e309ade0-8039-3969-e053-3a05fe0a2c94 1
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus, file e309ade0-8227-3969-e053-3a05fe0a2c94 1
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity, file e309ade0-b883-3969-e053-3a05fe0a2c94 1
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13), file e309ade1-06d1-3969-e053-3a05fe0a2c94 1
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad?, file e309ade1-a3d4-3969-e053-3a05fe0a2c94 1
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon, file e309ade4-837d-3969-e053-3a05fe0a2c94 1
Totale 106
Categoria #
all - tutte 551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 551


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 2 0 0 0 0
2020/20211 0 0 0 0 0 0 0 1 0 0 0 0
2021/20225 0 0 0 0 2 0 0 1 2 0 0 0
2022/202372 2 3 1 6 29 4 2 15 1 2 5 2
2023/202423 0 0 1 3 5 5 2 2 2 3 0 0
Totale 106